IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
15.47
-0.22 (-1.40%)
Nov 5, 2024, 11:13 AM EST - Market open
IGM Biosciences Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for IGM Biosciences stock have an average target of 14.38, with a low estimate of 8.00 and a high estimate of 25. The average target predicts a decrease of -7.05% from the current stock price of 15.47.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for IGMS stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 5 | 5 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $17 → $20 | Buy | Maintains | $17 → $20 | +29.28% | Oct 18, 2024 |
| Wedbush | Wedbush | Buy Maintains $25 → $22 | Buy | Maintains | $25 → $22 | +42.21% | Oct 1, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $20 → $17 | Buy | Maintains | $20 → $17 | +9.89% | Oct 1, 2024 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades $12 → $9 | Hold → Sell | Downgrades | $12 → $9 | -41.82% | Oct 1, 2024 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $24 → $12 | Strong Buy → Hold | Downgrades | $24 → $12 | -22.43% | Oct 1, 2024 |
Financial Forecast
Revenue This Year
8.49M
from 2.13M
Increased by 298.54%
Revenue Next Year
6.58M
from 8.49M
Decreased by -22.50%
EPS This Year
-3.16
from -4.71
EPS Next Year
-2.52
from -3.16
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 66.7M | 41.7M | 134.4M | ||
| Avg | 8.5M | 6.6M | 23.0M | ||
| Low | 2.0M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3,030.3% | 391.7% | 1,942.9% | ||
| Avg | 298.5% | -22.5% | 249.0% | ||
| Low | -8.0% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.71 | -1.33 | -1.30 | ||
| Avg | -3.16 | -2.52 | -2.30 | ||
| Low | -3.27 | -3.53 | -3.31 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.